← All topics
Finance & MarketsDaily pulse

Global markets respond to tech sector growth, pharmaceutical deal rumors, and evolving personal finance strategies.

Updated 24 sources

Key Points

Microsoft stock has erased its year-to-date losses, experiencing a rally not seen in 26 years as investors gain confidence in the company's capital spending returns.

Palantir Technologies saw its stock climb following strong earnings, fueled by significant growth in enterprise demand for autonomous AI models and data management.

A potential merger between AstraZeneca and Bristol Myers Squibb has triggered mixed market reactions, with analysts questioning the strategic logic behind a tie-up of these two pharmaceutical giants.

Market analysts note that recent outflows from stock-market timers are providing a contrarian bullish signal that may extend the current bull market.

Cathie Wood's ARK Invest has offloaded $5.5 million in a surging tech stock, while investors weigh the potential of upcoming IPOs like Jersey Mike's Subs.

New analysis highlights the financial reality of high-net-worth career transitions, including how a $100 million sports contract is significantly reduced by taxes and fees.

Personal finance experts are addressing retiree concerns regarding safe investment strategies for lump-sum pension payouts and the long-term impact of large real estate purchases on liquidity.

Pakistan has officially approved a new brownfield refinery policy, a long-awaited initiative intended to incentivize updates to the nation's five existing refineries.

Sources

24 articles · 3 outlets